AL
Neovacs S.A.
ALNEV.PA · PAR
0.26 € -0.08% (-0.00 €)
1M -61.88%
Market Cap 12.0 €
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/S 0.00x
P/B 0.00x
P/E N/A
Growth
78 /100
Growing Rev. growth 153.10%
Book val. growth 25.62%
EPS growth N/A
Profitability
2 /100
Weak Gross margin 11.58%
Net margin 8,984.51%
Op. margin 1,846.44%
Quality
0 /100
Poor ROIC 35.84%
ROA 149.13%
Asset turnover 0.02x
Debt
49 /100
Moderate Debt/Equity 0.01x
Current ratio 0.63x
Int. coverage -0.66x
Stability
13 /100
Unstable Beta -0.20x
Rev. volatility 27,673.52%
EPS volatility 12,224,508.23%
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o ALNEV.PA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Hugo Brugiere
Employees
16
Headquarters
Suresnes